Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety Study of Bevacizumab Biosimilars in the Real World

NCT05009017 is registered in ClinicalTrials.gov with Cancer Institute and Hospital, Chinese Academy of Medical Sciences as lead sponsor.

NCT NCT05009017
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05009017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety Study of Bevacizumab Biosimilars in the Real World
Lead sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2021
Completion date
December 31, 2022
Enrollment
272 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

biosimilar